Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Sold by IndexIQ Advisors LLC

IndexIQ Advisors LLC trimmed its stake in Prestige Consumer Healthcare Inc. (NYSE:PBHGet Rating) by 6.1% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 9,580 shares of the company’s stock after selling 620 shares during the quarter. IndexIQ Advisors LLC’s holdings in Prestige Consumer Healthcare were worth $581,000 at the end of the most recent quarter.

Several other institutional investors also recently made changes to their positions in the company. Banque Cantonale Vaudoise lifted its holdings in shares of Prestige Consumer Healthcare by 40.9% during the third quarter. Banque Cantonale Vaudoise now owns 1,075 shares of the company’s stock valued at $60,000 after purchasing an additional 312 shares during the last quarter. PNC Financial Services Group Inc. lifted its stake in Prestige Consumer Healthcare by 29.7% during the third quarter. PNC Financial Services Group Inc. now owns 3,293 shares of the company’s stock valued at $184,000 after buying an additional 754 shares in the last quarter. Advisor Group Holdings Inc. boosted its holdings in shares of Prestige Consumer Healthcare by 15.5% in the fourth quarter. Advisor Group Holdings Inc. now owns 3,331 shares of the company’s stock worth $203,000 after buying an additional 448 shares during the period. Advisor Partners LLC purchased a new position in shares of Prestige Consumer Healthcare in the fourth quarter worth approximately $209,000. Finally, FDx Advisors Inc. acquired a new stake in shares of Prestige Consumer Healthcare during the fourth quarter valued at approximately $212,000.

NYSE:PBH opened at $54.04 on Monday. The stock has a market cap of $2.71 billion, a PE ratio of 14.53, a PEG ratio of 1.58 and a beta of 0.65. Prestige Consumer Healthcare Inc. has a fifty-two week low of $43.21 and a fifty-two week high of $63.83. The company has a current ratio of 2.04, a quick ratio of 1.25 and a debt-to-equity ratio of 1.01. The firm’s 50-day simple moving average is $56.26.

Prestige Consumer Healthcare (NYSE:PBHGet Rating) last announced its quarterly earnings data on Thursday, February 3rd. The company reported $0.99 EPS for the quarter, beating the Zacks’ consensus estimate of $0.89 by $0.10. Prestige Consumer Healthcare had a net margin of 17.85% and a return on equity of 13.90%. The firm had revenue of $274.40 million for the quarter, compared to the consensus estimate of $260.39 million. During the same period in the previous year, the firm posted $0.81 earnings per share. The firm’s revenue was up 14.9% on a year-over-year basis. Sell-side analysts forecast that Prestige Consumer Healthcare Inc. will post 4.04 EPS for the current year.

Separately, StockNews.com started coverage on shares of Prestige Consumer Healthcare in a research note on Thursday, March 31st. They set a “buy” rating on the stock.

About Prestige Consumer Healthcare (Get Rating)

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.

Further Reading

Want to see what other hedge funds are holding PBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Prestige Consumer Healthcare Inc. (NYSE:PBHGet Rating).

Institutional Ownership by Quarter for Prestige Consumer Healthcare (NYSE:PBH)

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.